235 related articles for article (PubMed ID: 25658039)
21. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
Su SF; Huang SM; Han F; Huang Y; Chen CY; Xiao WW; Sun XM; Lu TX
Radiat Oncol; 2013 Jan; 8():17. PubMed ID: 23336282
[TBL] [Abstract][Full Text] [Related]
22. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
Huang XD; Li YC; Chen FP; Zheng WH; Zhou GQ; Lin L; Hu J; He WJ; Zhang LL; Kou J; Ma J; Zhang WD; Qi ZY; Sun Y
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):124-131. PubMed ID: 31075310
[TBL] [Abstract][Full Text] [Related]
23. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.
Lee AW; Foo W; Chappell R; Fowler JF; Sze WM; Poon YF; Law SC; Ng SH; O SK; Tung SY; Lau WH; Ho JH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):35-42. PubMed ID: 9422555
[TBL] [Abstract][Full Text] [Related]
24. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
25. Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
Yang SS; OuYang PY; Guo JG; Cai JJ; Zhang J; Peng QH; He Y; Zhang BY; Liu ZQ; Hu XF; Chen YF; Chen CY; Xie FY
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1291-1300. PubMed ID: 36462689
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
Chen YY; Zhao C; Wang J; Ma HL; Lai SZ; Liu Y; Han F; Lu LX; Bao Y; Chen M
Cancer; 2011 Jul; 117(13):2910-6. PubMed ID: 21264821
[TBL] [Abstract][Full Text] [Related]
27. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
29. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
[TBL] [Abstract][Full Text] [Related]
31. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
33. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.
Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X
Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728
[TBL] [Abstract][Full Text] [Related]
34. Radiation-induced nasopharyngeal ulcers after re-irradiation with intensity-modulated radiotherapy in locoregional recurrent nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
Ni MS; Kong FF; Pan GS; Du CR; Zhai RP; Hu CS; Ying HM
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1425-1434. PubMed ID: 37995006
[TBL] [Abstract][Full Text] [Related]
35. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.
He Y; Zhou Q; Shen L; Zhao Y; Lei M; Wei R; Shen L; Cao S
Radiat Oncol; 2015 Apr; 10():89. PubMed ID: 25881159
[TBL] [Abstract][Full Text] [Related]
37. Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies.
Xu Y; Liu Y; Wang Z; Wang J; Zhang J; Chen X; Wu R; Liu Q; Qu Y; Wang K; Huang X; Luo J; Gao L; Xu G; Zhang Y; Yi J
Radiat Oncol; 2022 Jan; 17(1):13. PubMed ID: 35062991
[TBL] [Abstract][Full Text] [Related]
38. Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy.
Xue F; Hu CS; He XY
Chin J Cancer; 2017 Sep; 36(1):76. PubMed ID: 28931426
[TBL] [Abstract][Full Text] [Related]
39. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
40. Research trends of radiation induced temporal lobe injury in patients with nasopharyngeal carcinoma from 2000 to 2022: a bibliometric analysis.
Guan Y; Yu BB; Liu S; Luo HY; Huang ST
Radiat Oncol; 2023 Sep; 18(1):151. PubMed ID: 37705085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
